Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry D Flandre

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|September 3, 2020
Biologic Immunomodulatory Drugs and Infection in the Respiratory Tract of Nonhuman PrimatesThierry D Flandre, Alessandro Piaia, Maurice G Cary
Toxicologic Pathology|August 21, 2020
Nonclinical Safety Assessment of an Inhaled Formulation of Serelaxin: A Recombinant Human Protein in Rats and Cynomolgus Monkeys (<i>Macaca fascicularis</i>)Thierry D Flandre, Adam S Hey, Fiona J Spence
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 7, 2003
Effect of somatic growth, strain, and sex on double-chamber plethysmographic respiratory function values in healthy miceThierry D Flandre, Pascal L Leroy, Daniel J-M Desmecht
Toxicologic Pathology|June 22, 2022
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology StudyThierry D Flandre, Keith G Mansfield, Pascal J Espié, et al.
International Journal of Toxicology|April 12, 2024
Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study ExamplesSmita Salian-Mehta, James D Smith, Thierry D Flandre, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|September 3, 2020
Biologic Immunomodulatory Drugs and Infection in the Respiratory Tract of Nonhuman PrimatesThierry D Flandre, Alessandro Piaia, Maurice G Cary
Toxicologic Pathology|August 21, 2020
Nonclinical Safety Assessment of an Inhaled Formulation of Serelaxin: A Recombinant Human Protein in Rats and Cynomolgus Monkeys (<i>Macaca fascicularis</i>)Thierry D Flandre, Adam S Hey, Fiona J Spence
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 7, 2003
Effect of somatic growth, strain, and sex on double-chamber plethysmographic respiratory function values in healthy miceThierry D Flandre, Pascal L Leroy, Daniel J-M Desmecht
Toxicologic Pathology|June 22, 2022
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology StudyThierry D Flandre, Keith G Mansfield, Pascal J Espié, et al.
International Journal of Toxicology|April 12, 2024
Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study ExamplesSmita Salian-Mehta, James D Smith, Thierry D Flandre, et al.
Pageof 1